Brookstone Capital Management Maia Biotechnology, Inc. Transaction History
Brookstone Capital Management
- $4.99 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
673KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA282KShares$1.06 Million0.0% of portfolio
-
Centric Wealth Management67.2KShares$253,3360.05% of portfolio
-
Geode Capital Management, LLC Boston, MA53.3KShares$200,7780.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$172,2890.0% of portfolio
-
Virtu Financial LLC New York, NY32.5KShares$122,4750.01% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $41.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...